Ipilimumab vs Methotrexate
Ipilimumab vs Methotrexate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methotrexate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Ipilimumab β Antibody; Methotrexate β Small molecule.